AURA Aura Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 11, 2026
$6,09
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$4,7352-Wochen-Tief
$9,5452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$630M
P/E
-3.5
EPS
$-1.76
Ihre Abzeichen
52W-Spanne
$5–$10
Analystenbewertung
BUY
Kursziel
$17
P/E
-3.5
ROE
-68.2%
Nettogewinnmarge
-1601.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
AURA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$6.09
Marktkapitalisierung (MRQ)
$630M
P/E
-3.5
EPS
$-1.76
ROE
-68.2%
52W-Spanne
$5–$10
AURA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-1.762021-12-31 → 2025-12-31
Freier Cashflow$-85M2021-12-31 → 2025-12-31
Nettogewinnmarge-1601.4%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | AURA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -3.55-Jahres-Durchschnitt ≈-3.9 | ≈-3.9 | · | · | |
| P/S | 58.45-Jahres-Durchschnitt ≈9615.9 | ≈9615.9 | 367.1 | Unterbewertet | |
| K/B (MRQ) | 2.05-Jahres-Durchschnitt ≈2.6 | ≈2.6 | 2.6 | Fairer Wert | |
| Kurs / FCF (TTM) | -6.15-Jahres-Durchschnitt ≈-7.7 | ≈-7.7 | · | · | |
| Kurs / Cashflow (TTM) | -6.15-Jahres-Durchschnitt ≈-8.0 | ≈-8.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 2.85-Jahres-Durchschnitt ≈2.5 | ≈2.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | AURA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Operating Margin (Betriebsgewinnmarge) | -1701.0%5-Jahres-Durchschnitt ≈-69277.2% | ≈-69277.2% | -2083.6% | Im Einklang | |
| EBITDA Margin (EBITDA-Marge) | -1701.0%5-Jahres-Durchschnitt ≈-69277.2% | ≈-69277.2% | -2083.6% | Im Einklang | |
| Pretax Margin (Vorgewinnmarge) | -1599.8% | · | -5050.3% | Spitzenklasse | |
| Net Profit Margin (Nettogewinnmarge) | -1601.4%5-Jahres-Durchschnitt ≈-69209.3% | ≈-69209.3% | -1978.2% | Im Einklang | |
| ROA | -60.4%5-Jahres-Durchschnitt ≈-42.4% | ≈-42.4% | -38.2% | Schwach | |
| ROE | -68.2%5-Jahres-Durchschnitt ≈-122.6% | ≈-122.6% | -43.9% | Schwach | |
| ROIC | -82.5% | · | -36.2% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | AURA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 16.85-Jahres-Durchschnitt ≈14.7 | ≈14.7 | 13.8 | Starke Liquidität | |
| Quick Ratio | 3.25-Jahres-Durchschnitt ≈9.4 | ≈9.4 | 6.4 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | AURA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -29.7%5-Jahres-Durchschnitt ≈3644.8% | ≈3644.8% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 52.7% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | AURA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.0 | Spitzenklasse |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-6.2%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $-0.48 | $-0.38 | -25.8% |
| 31. März 2026 | Mai 7, 2026 | $-0.50 | $-0.41 | -23.3% |
| 31. Dezember 2025 | $-0.37 | $-0.44 | 15.2% | |
| 30. September 2025 | $-0.40 | $-0.48 | 15.9% | |
| 30. Juni 2025 | $-0.47 | $-0.47 | -0.71% | |
| 31. März 2025 | $-0.55 | $-0.50 | -9.8% | |
| 31. Dezember 2024 | $-0.52 | $-0.45 | -14.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $90M | $73M | $65M | $42M | $25M | $18M | |
| SG&A Expense | $22M | $23M | $20M | $18M | $10M | $4M | |
| Operating Income | $-113M | $-96M | $-85M | $-60M | $-35M | $-22M | |
| Other Non-op | $77.0K | $-120.0K | $-76.0K | $-14.0K | $-1.0K | · | |
| Pretax Income | $-106M | $-87M | $-76M | $-59M | · | · | |
| Income Tax | $108.0K | $112.0K | $137.0K | $0 | $0 | $0 | |
| Net Income | $-106M | $-87M | $-76M | $-59M | $-35M | $-22M | |
| EPS (Basic) | $-1.76 | $-1.75 | $-1.93 | $-1.96 | $-8.95 | · | |
| EPS (Diluted) | $-1.76 | $-1.75 | $-1.93 | $-1.96 | $-8.95 | · | |
| Shares (Basic) | 60,337,608 | 49,650,480 | 39,620,036 | 29,937,228 | 5,159,973 | · | |
| Shares (Diluted) | 60,337,608 | 49,650,480 | 39,620,036 | 29,937,228 | 5,159,973 | · | |
| EBITDA | $-113M | $-96M | · | $-60M | $-35M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $32M | $41M | $122M | $149M | $17M | |
| Prepaid Expense | $5M | $10M | $6M | $8M | $5M | $1M | |
| Other Current Assets | $660.0K | $2M | $2M | $715.0K | $66.0K | $16.0K | |
| Current Assets | $150M | $161M | $232M | $197M | $154M | $18M | |
| PP&E (Net) | $3M | $3M | $3M | $5M | $5M | $4M | |
| PP&E (Gross) | $10M | $9M | $8M | $9M | $8M | $6M | |
| Accum. Depreciation | $7M | $6M | $5M | $4M | $3M | $2M | |
| Other Non-current Assets | $471.0K | $518.0K | $509.0K | $423.0K | · | · | |
| Total Assets | $169M | $183M | $255M | $224M | $160M | $22M | |
| Accounts Payable | $2M | $2M | $2M | $3M | $2M | $611.0K | |
| Current Liabilities | $18M | $15M | $12M | $10M | $7M | $3M | |
| Capital Leases | $14M | $16M | $17M | $18M | $360.0K | · | |
| Total Liabilities | $33M | $31M | $29M | $28M | $8M | $3M | |
| Paid-in Capital | $617M | $526M | $513M | $407M | $304M | $8M | |
| Retained Earnings | $-480M | $-374M | $-287M | $-211M | $-152M | $-117M | |
| Treasury Stock | $0 | · | · | · | · | · | |
| AOCI | $-102.0K | $263.0K | $539.0K | $-72.0K | · | · | |
| Stockholders' Equity | $137M | $152M | $226M | $196M | $152M | $-109M | |
| Liabilities + Equity | $169M | $183M | $255M | $224M | $160M | $22M | |
| Shares Outstanding | 63,587,777 | 49,998,279 | 49,350,788 | 37,771,918 | 29,211,643 | 381,123 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $12M | $9M | $6M | $2M | $736.0K | |
| Operating Cash Flow | $-85M | $-80M | $-64M | $-55M | $-32M | $-24M | |
| CapEx | $447.0K | $1M | $709.0K | $1M | $2M | $771.0K | |
| Investing Cash Flow | $36M | $69M | $-114M | $-68M | $-2M | $-771.0K | |
| Stock Issued | $47M | $0 | · | $87M | $79M | · | |
| Net Stock Activity | $47M | · | · | $87M | $79M | · | |
| Financing Cash Flow | $77M | $2M | $97M | $96M | $166M | $10M | |
| Net Change in Cash | · | $-9M | $-81M | $-27M | $132M | $-15M | |
| Taxes Paid | $100.0K | $100.0K | · | · | · | · | |
| Free Cash Flow | $-85M | $-81M | · | $-56M | $-35M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1701.0% | -1019.4% | · | -3234.7% | -271153.9% | · | |
| Net Margin | -1601.4% | -921.8% | · | -3152.5% | -271161.5% | · | |
| Pretax Margin | -1599.8% | -920.6% | · | · | · | · | |
| EBITDA Margin | -1701.0% | -1019.4% | · | -3234.7% | -271153.9% | · | |
| ROA | -60.4% | -39.7% | · | -30.6% | -38.7% | · | |
| ROE | -68.2% | -53.2% | · | -37.8% | -331.0% | · | |
| ROIC | -82.5% | -63.3% | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 10.8 | · | 18.8 | 21.1 | · | |
| Quick Ratio | 3.2 | 2.1 | · | 11.6 | 20.5 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.15 | $3.04 | · | $5.18 | $5.21 | · | |
| Revenue / Share | $0.11 | $0.19 | · | $0.06 | · | · | |
| Cash Flow / Share | $-1.40 | $-1.61 | · | $-1.82 | · | · | |
| Cash / Share | $0.94 | $0.63 | · | $3.22 | $5.10 | · | |
| EPS (TTM) | $-1.76 | $-1.75 | $-1.93 | $-1.96 | $-8.95 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -29.7% | 9.8% | 360.7% | 14238.5% | · | · | |
| Revenue CAGR 3Y | 52.7% | 798.5% | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $9M | $9M | $2M | $13.0K | · | |
| Net Income TTM | $-106M | $-87M | $-76M | $-59M | $-35M | · | |
| Market Cap | $347M | $411M | · | $397M | $496M | · | |
| P/E | -3.1 | -4.7 | -4.6 | -5.4 | -1.9 | · | |
| P/S | 52.3 | 43.6 | · | 212.8 | 38154.9 | · | |
| P/B | 2.5 | 2.7 | · | 2.0 | 3.3 | · | |
| P / Tangible Book | 2.5 | 2.7 | 1.9 | 2.0 | 3.3 | · | |
| P / Cash Flow | -4.1 | -5.1 | · | -7.3 | -15.3 | · | |
| P / FCF | -4.1 | -5.1 | · | -7.1 | -14.4 | · | |
| Earnings Yield | -32.3% | -21.3% | -21.8% | -18.7% | -52.7% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $31M | $28M | $22M | $22M | $23M | $23M | $22M | $17M | $17M | $17M | $20M | $15M | $15M | $14M | $13M | $11M | |
| SG&A Expense | $17M | $7M | $5M | $6M | $6M | $6M | $5M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | |
| Operating Income | $-48M | $-35M | $-27M | $-28M | $-29M | $-29M | $-28M | $-23M | $-23M | $-22M | $-25M | $-20M | $-20M | $-19M | $-18M | $-16M | |
| Other Non-op | $154.0K | $2.0K | $150.0K | $-13.0K | $-36.0K | $-24.0K | $-37.0K | $-25.0K | $-26.0K | $-32.0K | $-26.0K | $-5.0K | $-32.0K | $-13.0K | $303.0K | $-329.0K | |
| Pretax Income | $-46M | $-34M | $-26M | $-26M | $-27M | $-27M | $-26M | $-21M | $-20M | $-20M | $-22M | $-19M | $-18M | $-17M | · | · | |
| Income Tax | $29.0K | $11.0K | $16.0K | $26.0K | $48.0K | $18.0K | $24.0K | $43.0K | $0 | $46.0K | $137.0K | $0 | $0 | $0 | · | · | |
| Net Income | $-46M | $-34M | $-26M | $-26M | $-27M | $-27M | $-26M | $-21M | $-20M | $-20M | $-22M | $-19M | $-18M | $-17M | $-17M | $-16M | |
| EPS (Basic) | $-0.48 | $-0.50 | $-0.34 | $-0.40 | $-0.47 | $-0.55 | $-0.52 | $-0.42 | $-0.41 | $-0.40 | $-0.51 | $-0.48 | $-0.48 | $-0.46 | $-0.52 | $-0.54 | |
| EPS (Diluted) | $-0.48 | $-0.50 | $-0.34 | $-0.40 | $-0.47 | $-0.55 | $-0.52 | $-0.42 | $-0.41 | $-0.40 | $-0.51 | $-0.48 | $-0.48 | $-0.46 | $-0.52 | $-0.54 | |
| Shares (Basic) | 94,863,400 | 67,447,576 | · | 65,936,672 | 58,015,718 | 50,126,148 | · | 49,663,532 | 49,548,120 | 49,451,943 | · | 38,185,197 | 37,855,533 | 37,784,282 | · | 29,273,577 | |
| Shares (Diluted) | 94,863,400 | 67,447,576 | · | 65,936,672 | 58,015,718 | 50,126,148 | · | 49,663,532 | 49,548,120 | 49,451,943 | · | 38,185,197 | 37,855,533 | 37,784,282 | · | 29,273,577 | |
| EBITDA | $-48M | $-35M | · | $-28M | $-29M | $-29M | · | $-23M | $-23M | $-22M | · | $-20M | $-20M | $-19M | · | $-16M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $68M | $85M | $60M | $48M | $107M | $38M | $32M | $25M | $30M | $26M | $41M | $56M | $48M | $38M | $122M | $61M | |
| Prepaid Expense | $5M | $4M | $5M | $8M | $7M | $7M | $10M | $9M | $8M | $9M | $6M | $5M | $4M | $6M | $8M | $4M | |
| Other Current Assets | $819.0K | $1M | $1M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $566.0K | $988.0K | $771.0K | $715.0K | $306.0K | |
| Current Assets | $329M | $119M | $150M | $170M | $184M | $135M | $161M | $183M | $196M | $212M | $232M | $154M | $166M | $179M | $197M | $116M | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | |
| PP&E (Gross) | $10M | $10M | $10M | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $10M | $10M | $9M | $9M | $9M | |
| Accum. Depreciation | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | |
| Other Non-current Assets | $1M | $517.0K | $471.0K | $277.0K | $185.0K | $0 | $518.0K | $22.0K | $443.0K | $453.0K | $509.0K | $685.0K | $700.0K | $623.0K | $423.0K | · | |
| Total Assets | $348M | $138M | $169M | $190M | $204M | $155M | $183M | $205M | $218M | $235M | $255M | $180M | $193M | $206M | $224M | $143M | |
| Accounts Payable | $2M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $553.0K | $1M | $3M | $2M | |
| Current Liabilities | $20M | $17M | $18M | $19M | $15M | $12M | $15M | $15M | $11M | $10M | $12M | $11M | $9M | $8M | $10M | $10M | |
| Capital Leases | $13M | $14M | $14M | $15M | $15M | $15M | $16M | $16M | $16M | $17M | $17M | $17M | $17M | $18M | $18M | $18M | |
| Total Liabilities | $33M | $30M | $33M | $33M | $30M | $27M | $31M | $31M | $27M | $26M | $29M | $28M | $26M | $26M | $28M | $28M | |
| Common Stock | $1.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Paid-in Capital | $915M | $622M | $617M | $611M | $603M | $530M | $526M | $522M | $519M | $516M | $513M | $417M | $413M | $409M | $407M | $310M | |
| Retained Earnings | $-560M | $-514M | $-480M | $-455M | $-429M | $-402M | $-374M | $-348M | $-327M | $-307M | $-287M | $-265M | $-247M | $-228M | $-211M | $-194M | |
| Treasury Stock | $39M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $-670.0K | $-207.0K | $-102.0K | $69.0K | $25.0K | $105.0K | $263.0K | $607.0K | $-183.0K | $18.0K | $539.0K | $-134.0K | $-223.0K | $-45.0K | $-72.0K | $-147.0K | |
| Stockholders' Equity | $315M | $107M | $137M | $157M | $175M | $128M | $152M | $175M | $191M | $209M | $226M | $152M | $166M | $180M | $196M | $115M | |
| Liabilities + Equity | $348M | $138M | $169M | $190M | $204M | $155M | $183M | $205M | $218M | $235M | $255M | $180M | $193M | $206M | $224M | $143M | |
| Shares Outstanding | 103,480,053 | 64,150,468 | 63,587,777 | 62,985,569 | 62,071,050 | 50,225,312 | 49,998,279 | 49,778,861 | 49,583,358 | 49,504,405 | 49,350,788 | 38,216,717 | 38,086,606 | 37,800,102 | 37,771,918 | 29,283,285 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $12M | $4M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-33M | $-30M | $-20M | $-20M | $-21M | $-23M | $-24M | $-15M | $-16M | $-24M | $-17M | $-15M | $-15M | $-16M | $-18M | $-11M | |
| CapEx | $21.0K | $102.0K | $176.0K | $45.0K | $39.0K | $187.0K | $299.0K | $341.0K | $525.0K | $88.0K | $317.0K | $90.0K | $193.0K | $109.0K | $358.0K | $63.0K | |
| Investing Cash Flow | $-226M | $55M | $30M | $-44M | $20M | $30M | $30M | $10M | $20M | $9M | $-90M | $22M | $21M | $-67M | $-17M | $18M | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $242M | $300.0K | $3M | $4M | $70M | $96.0K | $543.0K | $716.0K | $83.0K | $253.0K | $93M | $2M | $2M | $201.0K | $95M | $104.0K | |
| Net Change in Cash | · | · | · | · | · | · | · | $-5M | $4M | $-15M | $-15M | $8M | $9M | $-83M | $60M | $7M | |
| Free Cash Flow | · | $-30M | · | · | · | $-24M | · | · | · | $-25M | · | · | · | $-17M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2083.6% | -2929.9% | · | -1537.5% | -1705.2% | -1821.5% | · | -1028.9% | -928.7% | -831.0% | · | -1034.2% | -1009.3% | -976.6% | · | -3324.0% | |
| Net Margin | -1978.2% | -2830.7% | · | -1439.7% | -1610.2% | -1724.1% | · | -931.9% | -829.7% | -733.9% | · | -934.5% | -910.8% | -877.3% | · | -3292.1% | |
| Pretax Margin | -1976.9% | -2829.8% | · | -1438.2% | -1607.3% | -1723.0% | · | -930.0% | -829.7% | -732.2% | · | · | · | · | · | · | |
| EBITDA Margin | -2083.6% | -2929.9% | · | -1537.5% | -1705.2% | -1821.5% | · | -1028.9% | -928.7% | -831.0% | · | -1034.2% | -1009.3% | -976.6% | · | -3324.0% | |
| ROA | -16.5% | -23.0% | · | -13.2% | -12.8% | -14.1% | · | -10.9% | -9.9% | -8.9% | · | -11.5% | -11.2% | -9.9% | · | -13.6% | |
| ROE | -18.6% | -28.6% | · | -15.8% | -14.8% | -16.3% | · | -12.9% | -11.4% | -10.1% | · | -13.9% | -12.4% | -10.9% | · | 199.2% | |
| ROIC | -15.3% | -32.5% | · | -17.8% | -16.4% | -22.7% | · | -13.3% | · | -10.7% | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.8 | 7.1 | · | 9.0 | 12.4 | 11.1 | · | 12.5 | 18.5 | 22.0 | · | 14.1 | 18.7 | 22.1 | · | 11.6 | |
| Quick Ratio | 3.5 | 5.1 | · | 2.5 | 7.2 | 3.1 | · | 1.7 | 2.9 | 2.7 | · | 5.1 | 5.4 | 4.7 | · | 6.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.05 | $1.67 | · | $2.49 | $2.81 | $2.55 | · | $3.51 | $3.86 | $4.22 | · | $3.97 | $4.37 | $4.77 | · | $3.93 | |
| Revenue / Share | $0.02 | $0.02 | · | $0.03 | $0.03 | $0.03 | · | $0.05 | $0.05 | $0.05 | · | $0.05 | $0.05 | $0.05 | · | $0.02 | |
| Cash Flow / Share | · | $-0.44 | · | · | · | $-0.47 | · | · | · | $-0.49 | · | · | · | $-0.43 | · | · | |
| Cash / Share | $0.66 | $1.32 | · | $0.76 | $1.73 | $0.76 | · | $0.51 | $0.61 | $0.53 | · | $1.45 | $1.25 | $1.02 | · | $2.09 | |
| EPS (TTM) | $-1.72 | $-1.71 | · | $-1.94 | $-1.96 | $-1.90 | · | $-1.74 | $-1.80 | $-1.87 | · | $-1.94 | $-2.00 | $-1.98 | · | $67.54 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $6M | · | $7M | $8M | $8M | · | $10M | $10M | $9M | · | $7M | $6M | $4M | · | $805.0K | |
| Net Income TTM | $-131M | $-112M | · | $-106M | $-101M | $-95M | · | $-83M | $-81M | $-79M | · | $-71M | $-68M | $-63M | · | $-54M | |
| Market Cap | $735M | $429M | · | $389M | $389M | $294M | · | $444M | $375M | $389M | · | $343M | $470M | $351M | · | $531M | |
| P/E | -4.1 | -3.9 | · | -3.2 | -3.2 | -3.1 | · | -5.1 | -4.2 | -4.2 | · | -4.6 | -6.2 | -4.7 | · | 0.3 | |
| P/S | 107.2 | 68.9 | · | 54.7 | 51.4 | 35.3 | · | 44.3 | 38.5 | 41.9 | · | 48.7 | 84.8 | 91.6 | · | 659.1 | |
| P/B | 2.3 | 4.0 | · | 2.5 | 2.2 | 2.3 | · | 2.5 | 2.0 | 1.9 | · | 2.3 | 2.8 | 1.9 | · | 4.6 | |
| P / Tangible Book | 2.3 | 4.0 | · | 2.5 | 2.2 | 2.3 | · | 2.5 | 2.0 | 1.9 | · | 2.3 | 2.8 | 1.9 | · | 4.6 | |
| P / Cash Flow | · | -14.4 | · | · | · | -12.6 | · | · | · | -15.9 | · | · | · | -21.4 | · | · | |
| Earnings Yield | -24.2% | -25.6% | · | -31.4% | -31.3% | -32.4% | · | -19.5% | -23.8% | -23.8% | · | -21.6% | -16.2% | -21.3% | · | 372.7% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Betriebsgewinnmarge % | -1701.0% | -1019.4% | · | -3234.7% | -271153.9% |
| Nettoergebnis | $-106M | $-87M | $-76M | $-59M | $-35M |
| Verwässerte EPS | $-1.76 | $-1.75 | $-1.93 | $-1.96 | $-8.95 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 8.1 | 10.8 | · | 18.8 | 21.1 |
| Quick Ratio | 3.2 | 2.1 | · | 11.6 | 20.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-85M | $-81M | · | $-56M | $-35M |
Institutionelle Eigentümer (13F) 153 Einreicher · $721.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
153
Gehaltener Wert
$721.0M
Neue Positionen
38
Geschlossene Positionen
13
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 38 (+11 vs. Vorquartal) | 13 (+1 vs. Vorquartal) | 56 (+20 vs. Vorquartal) | 29 (-11 vs. Vorquartal) | +41.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $67.686.664 | 9.533.333 | 9,39% | Aktien |
| MONTANOVA CAPITAL, LLC | $51.164.141 | 7.206.217 | 7,10% | Aktien |
| Frazier Life Sciences Management, L.P. | $50.410.000 | 7.100.000 | 6,99% | Aktien |
| Matrix Capital Management Company, LP | $46.314.000 | 6.922.870 | 6,42% | Aktien |
| Long Focus Capital Management, LLC | $36.349.032 | 5.119.582 | 5,04% | Aktien |
| BlackRock, Inc. | $33.424.486 | 4.707.674 | 4,64% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $32.944.000 | 4.640.000 | 4,57% | Aktien |
| Caligan Partners LP | $30.517.561 | 4.298.248 | 4,23% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $29.112.428 | 4.100.342 | 4,04% | Aktien |
| FCPM III SERVICES B.V. | $28.781.803 | 4.053.775 | 3,99% | Aktien |
| ORBIMED ADVISORS LLC | $23.666.664 | 3.333.333 | 3,28% | Aktien |
| Medicxi Ventures Management (Jersey) Ltd | $21.583.233 | 3.039.892 | 2,99% | Aktien |
| Nantahala Capital Management, LLC | $20.952.313 | 2.951.030 | 2,91% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $17.750.000 | 2.500.000 | 2,46% | Aktien |
| Balyasny Asset Management L.P. | $16.717.795 | 2.354.619 | 2,32% | Aktien |
| VANGUARD GROUP INC | $16.004.132 | 2.936.538 | 2,22% | Aktien |
| FRANKLIN RESOURCES INC | $14.716.355 | 2.072.726 | 2,04% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $12.462.919 | 1.754.721 | 1,73% | Aktien |
| Redmile Group, LLC | $11.833.336 | 1.666.667 | 1,64% | Aktien |
| EcoR1 Capital, LLC | $11.833.336 | 1.666.667 | 1,64% | Aktien |
| Trails Edge Capital Partners, LP | $10.247.665 | 1.443.333 | 1,42% | Aktien |
| Foresite Capital Management VI LLC | $9.466.671 | 1.333.334 | 1,31% | Aktien |
| STATE STREET CORP | $8.683.186 | 1.222.984 | 1,20% | Aktien |
| Woodline Partners LP | $8.592.299 | 1.210.183 | 1,19% | Aktien |
| Bellevue Group AG | $8.283.336 | 1.166.667 | 1,15% | Aktien |
| Vivo Capital, LLC | $8.283.336 | 1.166.667 | 1,15% | Aktien |
| ACORN CAPITAL ADVISORS, LLC | $6.596.447 | 929.077 | 0,91% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $6.435.128 | 906.356 | 0,89% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.186.528 | 871.342 | 0,86% | Aktien |
| LEVIN CAPITAL STRATEGIES, L.P. | $5.950.276 | 838.067 | 0,83% | Aktien |
| B Group, Inc. | $5.426.125 | 764.243 | 0,75% | Aktien |
| STEMPOINT CAPITAL LP | $5.071.388 | 714.280 | 0,70% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.524.148 | 637.204 | 0,63% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $4.392.726 | 618.891 | 0,61% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $4.384.016 | 617.467 | 0,61% | Aktien |
| AWM Investment Company, Inc. | $4.198.123 | 591.285 | 0,58% | Aktien |
| NORTHERN TRUST CORP | $3.901.181 | 549.462 | 0,54% | Aktien |
| Regency Capital Management Inc.\DE | $3.836.804 | 540.395 | 0,53% | Aktien |
| GOLDMAN SACHS GROUP INC | $3.299.143 | 464.668 | 0,46% | Aktien |
| FMR LLC | $1.812.851 | 255.331 | 0,25% | Aktien |
| MORGAN STANLEY | $1.240.313 | 174.692 | 0,17% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.236.820 | 174.200 | 0,17% | Aktien |
| Integral Health Asset Management, LLC | $1.207.000 | 170.000 | 0,17% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.158.408 | 163.156 | 0,16% | Aktien |
| XTX Topco Ltd | $1.064.510 | 149.931 | 0,15% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $938.066 | 132.122 | 0,13% | Aktien |
| Quantinno Capital Management LP | $927.658 | 130.656 | 0,13% | Aktien |
| ADAR1 Capital Management, LLC | $924.079 | 130.152 | 0,13% | Aktien |
| Bank of New York Mellon Corp | $842.009 | 118.593 | 0,12% | Aktien |
| PLATINUM INVESTMENT MANAGEMENT LTD | $794.242 | 111.865 | 0,11% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Matrix Capital Management Company LP, David E. Goel ×5 Einreichungen | 11. Mai 2026 | 0,00% | Änderung | · | SEC |
| Medicxi Growth I LP, Medicxi Growth Co-Invest I LP, Medicxi Growth I GP Limited, Medicxi Ventures Management (Jersey) Limited | 10. November 2021 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 20 Insider · 14 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Natalie C. Holles | Chief Executive Officer and President | 19. Mai 2026 A | 1.153.962 | 0 | 0 | $0 |
| Pinos Elisabet De Los | President and Chief Executive Officer | 2. März 2026 A | 575.815 | 0 | 3 | $-380.830 |
| Julie B Feder | Chief Financial Officer | 18. Oktober 2024 M | 134.276 | 0 | 0 | $0 |
| Susan Abu-Absi | Chief Operating Officer | 1. September 2026 A | 134.513 | 0 | 0 | $0 |
| Mark De Rosch | Chief Operating Officer | 19. Januar 2023 A | 58.635 | 0 | 0 | $0 |
| Erica Kratz | Chief Reg. & Quality Officer | 1. September 2026 A | 100.885 | 0 | 0 | $0 |
| Amy Elazzouzi | SVP, Finance & PAO | 1. September 2026 A | 143.600 | 0 | 3 | $-56.632 |
| Janet Jill Hopkins | Chief Medical Officer | 1. September 2026 A | 380.190 | 0 | 2 | $-195.960 |
| Julie Person | Chief People Officer | 1. September 2026 A | 107.611 | 0 | 0 | $0 |
| Conor Kilroy | Chief Legal Officer and Secretary | 1. Juli 2026 A | 232.693 | 0 | 2 | $-143.400 |
| Anthony S Gibney | Chief Financial and Business Officer. | 16. Juni 2026 S | 265.354 | 0 | 1 | $-82.330 |
| Mark Plavsic | Chief Technology Officer | 2. März 2026 A | 243.736 | 0 | 2 | $-157.517 |
| Cadmus Rich | Chief Medical Officer, Head of R&D | 19. Januar 2023 A | 58.703 | 0 | 0 | $0 |
| Christopher Brett Primiano | Chief Business Officer | 28. Oktober 2021 A | 8.750 | 0 | 0 | $0 |
| Jeremy Bender | Direktor | 7. Juli 2026 A | 30.000 | 0 | 0 | $0 |
| Teresa Marie Bitetti | Direktor | 11. Juni 2026 A | 36.000 | 0 | 0 | $0 |
| David Michael Johnson | Direktor | 11. Juni 2026 A | 194.167 | 0 | 0 | $0 |
| Antony C. Mattessich | Direktor | 11. Juni 2026 A | 38.500 | 0 | 0 | $0 |
| Sapna Srivastava | Direktor | 11. Juni 2026 A | 38.500 | 0 | 0 | $0 |
| Rajesh R Parekh | Direktor | 7. Juni 2023 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 34 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,73% | 48.490 NS | 31. Juli 2026 | N-PORT |
| EIS · iShares, Inc. | 0,22% | 340.652 SH | 11. September 2026 | Täglich |
| VNQI · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,09% | 544.349 SH | 19. August 2026 | Täglich |
| IWC · iShares Trust | 0,07% | 151.855 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 7.337 SH | 1. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,03% | 500.783 SH | 11. September 2026 | Täglich |
| SCZ · iShares Trust | 0,03% | 558.487 SH | 11. September 2026 | Täglich |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 568.052 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 44.692 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 394.396 SH | 11. September 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 1.149.779 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 21.415 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.107.800 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 257.523 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 280.365 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 10.684 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 174.907 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 31.521 SH | 1. Oktober 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 3.128 NS | 31. Juli 2026 | N-PORT |
| IEFA · iShares Trust | 0,00% | 531.838 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 182.735 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 3.190 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 8.911 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 8.950 SH | 3. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 5.875 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.902.292 SH | 19. August 2026 | Täglich |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 2.197.085 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 117.433 SH | 19. August 2026 | Täglich |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 1.463.808 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.555 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.743 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 2.107 NS | 31. Juli 2026 | N-PORT |
| VSGX · VANGUARD WORLD FUND | 0,00% | 33.754 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 39.492 SH | 11. September 2026 | Täglich |
AURA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 12 Analysten
KAUF
Median-Ziel
$15.00
+146,3%
3 25,0%
Starker Kauf
8 66,7%
Kauf
1 8,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
5 Analysten · 2026-09-28Mittelwert-Ziel $16.60 +172,6%
← Unter allen Zielen
Aktueller Preis $6.09
Tief$12.00
Mittelwert$16.60
Hoch$23.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
| CTMX | $725M | · | -44.8% | -22.8% | -15.9% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 11, 2026